Esplanade Healthtech Ventures

About

Portfolio

Q&A

What is Esplanade Healthtech Ventures' primary investment focus?

Esplanade Healthtech Ventures is a venture capital firm focused on early-stage digital health and healthcare technology companies, particularly those with AI-enabled solutions.

When was Esplanade Healthtech Ventures founded and where is it headquartered?

Esplanade Healthtech Ventures was founded in 2019 and is headquartered in Montreal, Canada, with additional offices in Toronto.

What investment stages does Esplanade Healthtech Ventures typically target?

Esplanade Healthtech Ventures invests in Pre-Seed, Seed, and Series A rounds, with selective participation in Series B rounds.

What geographies does Esplanade Healthtech Ventures prefer for investments?

Esplanade Healthtech Ventures prefers to invest in companies located in Canada, the US, Europe, and Israel.

What is the typical check size for Esplanade Healthtech Ventures?

Esplanade Healthtech Ventures typically invests between $367,500 and $3,675,000 USD per company.

Has Esplanade Healthtech Ventures raised any funds?

Yes, Esplanade Healthtech Ventures raised a fund named Esplanade HealthTech Ventures I in 2021 with a size of $15,435,000 USD.

Who are some of the key team members at Esplanade Healthtech Ventures?

Key team members include Co-Founder & Chairman Dr. Sheldon Elman, Co-Founder Stuart M. Elman, and Managing Partner Ella Seitz.

What kind of support does Esplanade Healthtech Ventures provide to its portfolio companies?

Esplanade Healthtech Ventures provides capital, strategic advisory, and distribution support to its portfolio companies, leveraging its team's extensive industry experience.